{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:04:25Z","timestamp":1791374665809,"version":"4.3.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014812","name":"Nordic Pharma Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jbspin.2021.105200","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T13:37:33Z","timestamp":1619617053000},"page":"105200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Rheumatoid arthritis and depression"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3522-4584","authenticated-orcid":false,"given":"Eric","family":"Fakra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1177-9497","authenticated-orcid":false,"given":"Hubert","family":"Marotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2021.105200_bib0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2021.105200_bib0310","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2021.105200_bib0315","doi-asserted-by":"crossref","first-page":"53623","DOI":"10.18632\/oncotarget.17323","article-title":"The prevalence of depression in rheumatoid arthritis in China: a systematic review","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbspin.2021.105200_bib0320","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/dme.12973","article-title":"Prevalence of depression in Type 1 diabetes and the problem of over-diagnosis","volume":"33","author":"Fisher","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jbspin.2021.105200_bib0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0330","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/acr.23539","article-title":"Increased burden of psychiatric disorders in rheumatoid arthritis","volume":"70","author":"Marrie","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40744-017-0058-2","article-title":"Depression risk in patients with rheumatoid arthritis in the United Kingdom","volume":"4","author":"Jacob","year":"2017","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2021.105200_bib0340","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1185\/03007991003795808","article-title":"Association between tendency towards depression and severity of rheumatoid arthritis from a national representative sample: the Medical Expenditure Panel Survey","volume":"26","author":"Godha","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2021.105200_bib0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14737167.2017.1281744","article-title":"Healthcare burden of depression in adults with arthritis","volume":"17","author":"Sambamoorthi","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0350","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2021.105200_bib0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.jbspin.2021.105200_bib0360","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0005-7967(97)00025-9","article-title":"Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care","volume":"35","author":"Beck","year":"1997","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.jbspin.2021.105200_bib0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale: an updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0370","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1002\/acr.20556","volume":"63","author":"Smarr","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0375","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a Brief Depression Severity Measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jbspin.2021.105200_bib0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1982","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1297-6","article-title":"Comparison of depression prevalence estimates in meta-analyses based on screening tools and rating scales versus diagnostic interviews: a meta-research review","volume":"17","author":"Levis","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jbspin.2021.105200_bib0390","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/acr.24011","article-title":"Validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis","volume":"72","author":"Hitchon","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0395","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/annrheumdis-2017-212867","article-title":"Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis","volume":"78","author":"Boer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2021.105200_bib0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.genhosppsych.2018.06.001","article-title":"Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases","volume":"53","author":"Marrie","year":"2018","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0405","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/rheumatology\/kes356","article-title":"The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review","volume":"52","author":"Rathbun","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2021.105200_bib0410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/BOR.0000000000000597","article-title":"Depression and the risk of rheumatoid arthritis","volume":"31","author":"Vallerand","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0415","first-page":"20646","article-title":"Bidirectional associations between rheumatoid arthritis and depression: a nationwide longitudinal study","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2021.105200_bib0420","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000670","article-title":"Original article: depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study","volume":"4","author":"Vallerand","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2021.105200_bib0425","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers\u2013A meta-analysis","volume":"80","author":"Wi\u0119d\u0142ocha","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.24441","article-title":"Depression and subsequent risk for incident rheumatoid arthritis among women","volume":"73","author":"Sparks","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0435","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/acr.22683","article-title":"Posttraumatic stress disorder and risk for incident rheumatoid arthritis","volume":"68","author":"Lee","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0440","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/03009742.2017.1324910","article-title":"Stressful life events as a trigger for rheumatoid arthritis onset within a year: a case\u2013control study","volume":"46","author":"Gross","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0445","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/ijerph15081783","article-title":"Postpartum depression and subsequent autoimmune diseases in Taiwan","volume":"15","author":"Lin","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jbspin.2021.105200_bib0450","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jid.2016.11.032","article-title":"Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study","volume":"137","author":"Lewinson","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0455","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/gutjnl-2018-317182","article-title":"Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression","volume":"68","author":"Frolkis","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jbspin.2021.105200_bib0460","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2018.7028","article-title":"Association of stress-related disorders with subsequent autoimmune disease","volume":"319","author":"Song","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2021.105200_bib0465","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","article-title":"Rheumatoid arthritis and depression: an inflammatory perspective","volume":"6","author":"Nerurkar","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0470","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jbspin.2021.105200_bib0475","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/JIR.S141033","article-title":"The role of neuroinflammation and neurovascular dysfunction in major depressive disorder","volume":"11","author":"Jeon","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0480","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopsych.2018.09.031","article-title":"The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology","volume":"85","author":"Belleau","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0485","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0490","first-page":"S316","article-title":"Major depressive disorder: psychosocial impairment and key considerations in functional improvement - PubMed","volume":"15","author":"Papakostas","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jbspin.2021.105200_bib0495","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.01.014","article-title":"Duration of untreated depression influences clinical outcomes and disability","volume":"175","author":"Ghio","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2021.105200_bib0500","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jad.2018.11.038","article-title":"Definition of treatment-resistant depression\u2013Asia Pacific perspectives","volume":"245","author":"Ng","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2021.105200_bib0505","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0510","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2019.07.045","article-title":"Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review","volume":"257","author":"Yang","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2021.105200_bib0515","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jpsychires.2009.05.010","article-title":"Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression","volume":"43","author":"Dhabhar","year":"2009","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jbspin.2021.105200_bib0520","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2018.12.037","article-title":"Inflammatory profiles of severe treatment-resistant depression","volume":"246","author":"Strawbridge","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2021.105200_bib0530","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12888-018-1845-1","article-title":"N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0535","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12325-016-0455-x","article-title":"Sirukumab: a potential treatment for mood disorders?","volume":"34","author":"Zhou","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jbspin.2021.105200_bib0540","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/ijms17050733","article-title":"Pathogenetic and therapeutic applications of tumor necrosis factor-\u03b1 (TNF-\u03b1) in major depressive disorder: a systematic review","volume":"17","author":"Ma","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2021.105200_bib0545","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","article-title":"Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression","volume":"98","author":"Bekhbat","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jbspin.2021.105200_bib0550","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2013.04.004","article-title":"Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression","volume":"31","author":"Mehta","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jbspin.2021.105200_bib0555","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pnpbp.2019.01.010","article-title":"LDL cholesterol relates to depression, its severity, and the prospective course","volume":"92","author":"Wagner","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0560","first-page":"881","article-title":"A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue","volume":"43","author":"Hoseth","year":"2017","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jbspin.2021.105200_bib0565","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0570","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2018.04.037","article-title":"Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression","volume":"235","author":"Huang","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jbspin.2021.105200_bib0575","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/19420862.2016.1264550","article-title":"Physicochemical and biological characterization of SB2, a biosimilar of Remicade\u00ae (infliximab)","volume":"9","author":"Hong","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.jbspin.2021.105200_bib0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0585","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar1465","article-title":"Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response","volume":"7","author":"Marotte","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2021.105200_bib0590","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jbspin.2021.105200_bib0595","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"K\u00f6hler","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jbspin.2021.105200_bib0600","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pnpbp.2018.01.003","article-title":"Targeting cytokines in reduction of depressive symptoms: a comprehensive review","volume":"83","author":"Shariq","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X21000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X21000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:27:04Z","timestamp":1761150424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X21000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1297319X21000725"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2021.105200","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis and depression","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2021.105200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105200"}}